Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze
The major research funder CRUK and two of the biotech companies it works with have…
16/02/2021 - 4 minutes
Cancer
How Vaccine Platforms Can Prepare Us for Future Pandemics
The Covid-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be a powerful…
15/02/2021 - 7 minutes
Can Covid-19 Vaccines Keep up with an Evolving Virus?
The first generation of vaccines for Covid-19 is rolling out all over the world. But…
11/02/2021 - 7 minutes
Top Neurotech Startups Unlocking the Brain in Russia
Russia has established itself as a hub for neurotech startups, attracting scientists and business people…
10/02/2021 - 6 minutes
Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
26/01/2021 - 7 minutes
Investors Up the Ante for Drugs Striking Cancer via DNA Repair
A colossal deal struck last month between Germany’s Merck KGaA and UK-based Artios Pharma is…
19/01/2021 - 5 minutes
Wave of Acquisitions Hits ADC Cancer Treatment Space
The end of 2020 saw several big pharma acquisitions of companies developing antibody-drug conjugate drugs…
05/01/2021 - 7 minutes
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
17/12/2020 - 6 minutes
Sponsored
by CrownBio
Report: Are Tumor Organoids the Future of Cancer Drug Development?
Over the last decade, oncology drug development has been marred by the high attrition rates…
01/12/2020 - 3 minutes
SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’
The newly founded SynOx has become the latest startup to attack solid tumors via their…
23/11/2020 - 4 minutes
Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
16/11/2020 - 3 minutes
Navigating the Immunotherapy Maze
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
11/11/2020 - 2 minutes
